[PDF][PDF] 多重耐药类香菌属致眼内炎患者的药学监护

李晓庄, 赵曜, 殷文静, 吴俊姬 - 医药导报, 2023 - yydbzz.com
Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage
occurrence: data from a multiethnicꎬ multinational Latin American Lupus Cohort (GLADEL) [ J]. …

[HTML][HTML] 系统性红斑狼疮低疾病活动度及缓解状况的真实世界研究

任立敏, 赵楚楚, 赵义, 周惠琼, 张莉芸… - Journal of Peking …, 2024 - ncbi.nlm.nih.gov
Low disease activity and remission status of systemic lupus erythematosus in a real-world …
of low disease activity and remission were calculated based on the lupus low disease activity

[PDF][PDF] 基于知信行干预理论的药学服务模式在系统性红斑狼疮患者中的实施效果*

张春歌, 唐婕, 龚银华, 吴憩 - 医药导报, 2023 - yydbzz.com
… Predictors of low disease activity and clinical remission following belimumab … Remission
and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data …

系统性红斑狼疮治疗的新策略

M Gatto, M Zen, L Iaccarino, A Doria - www. nature. com/nrrheum, 2019 - zh-pdf.nature.com
… 活动度(Low disease activity, LDA) 的概念以及SLE 的长期治疗缺乏共识, … This paper highlights
the occurrence of immunological … Both prolonged remission and lupus low disease activity